リガンド結合による刺激反応性融合ポリペプチドの逆相移行のアロステリックアクチュエーション
Bumjoon Kim1, Ashutosh Chilkoti
1Department of Biomedical Engineering, Duke University, Durham, North Carolina 27708-0281, USA.
Journal of the American Chemical Society
|December 6, 2008
まとめ
私たちは,ポリマーの相変化を制御するためにリガンド結合を使用する新しいバイオポリマーアクチュエータを開発しました. このイノベーションにより,生物学的信号に反応するスマート素材が,薬物投与および診断におけるアプリケーションを可能にします.
科学分野:
- バイオマテリアル科学 バイオマテリアル科学
- ポリマー化学のポリマー化学について
- 分子工学は分子工学である.
背景:
- エラスティン型ポリペプチド (ELP) のような刺激反応性ポリマーは,調節可能な相移行を示します.
- これらの相転換を特定の生化学的トリガーで制御することは,依然として課題です.
研究 の 目的:
- リガンド結合を水性脱混合相移行にリンクするバイオポリマーアクチュエータを設計する.
- エラスティン型ポリペプチド (ELP) のアロステリック調節を証明するために,生物分子認識による低臨界溶液温度 (LCST) 段階移行.
主な方法:
- カルモジュリン (CaM) とELPドメインを融合させ,モジュラー型バイオポリマーアクチュエータを構築しました.
- カルシウムのCaMへの結合と,ELPの相変化行動への影響について調査した.
- CaM-ELPシステムの可逆性,選択性,および特異性を評価しました.
主要な成果:
- カルシウムのCaMへの結合は,ELPの可逆的なLCST相移行をアロステリックで誘発し,粒子を形成しました.
- 粒子の形成はELP鎖の長さに依存し,カルシウムケレーションによって逆転する.
- このシステムは,カルシウムに対してマグネシウムに対する選択性と,ペプチドリガンドに対する特異性を実証した.
結論:
- ポリマーLCST相変異の生物分子認識誘発によるアロステリック調節の最初の実証を達成しました.
- 刺激反応性ポリマーのトリガーの範囲を拡大し,生化学的リガンド結合を含む.
- このモジュラーデザインは,薬物投与,プロテオミクス,ナノスケールデバイスにおける"スマート"ポリマーアクチュエータの可能性を秘めています.
関連する概念動画
Ligand Binding and Linkage
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence the...
Cooperative Allosteric Transitions
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
Cooperative Allosteric Transitions
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
Cooperative Allosteric Transitions
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
The Two-State Receptor Model
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with one...
The binding affinity of a drug determines its interaction with one...


